Notes
to Unaudited Condensed Consolidated Financial Statements
For
the Three Months Ended March 31, 2023
NOTE
1 – NATURE OF OPERATIONS
China Foods Holdings Ltd. (the “Company”
or “CFOO”) was incorporated in Delaware on January 10, 2019.
The Company is a health and wellness company that
develops, markets, promotes and distributes a variety of customized health and wellness care products and services, including supplements,
healthy snacks, meal replacements, skincare products, and nutritional consultation services to consumers in China. The Company works with
certain licensed healthcare food factories to develop and manufacture products and services that are distributed conventionally through
sales agents and also through a network of e-commerce and social media platforms.
Due to the impact of the COVID-19 pandemic in the
healthcare industry, the Company also offered a new line of high-end wine products in our online and offline sales platform, to diversify
the market demand and customer needs.
The
following table depicts the description of the Company’s subsidiaries:
SCHEDULE
OF SUBSIDIARIES INFORMATION
Name | |
Place of incorporation and kind of legal entity | |
Principal activities | |
Particulars of registered/ paid up share capital | |
Effective interest held | |
| |
| |
| |
| |
| |
Elite Creation Group Limited | |
BVI, a limited liability company | |
Investment holding | |
50,000 issued shares of US$1each | |
| 100 | % |
| |
| |
| |
| |
| | |
Alpha Wellness (HK) Limited | |
Hong Kong, a limited liability company | |
Investment holding | |
300,000 issued shares for HK$300,000 | |
| 100 | % |
| |
| |
| |
| |
| | |
Guangzhou Xiao Xiang Health Industry Company Limited | |
The PRC, a limited liability company | |
Sales of healthcare products | |
RMB 8,300,000 | |
| 100 | % |
NOTE
2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of presentation and consolidation
The
accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally
accepted accounting principles in the United States (“GAAP”) for interim financial reporting, and in accordance with
instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes
required by generally accepted accounting principles for complete financial statements. In the opinion of management, the unaudited
condensed consolidated financial statements contained in this report reflect all adjustments that are normal and recurring in nature
and considered necessary for a fair presentation of the financial position and the results of operations for the interim periods
presented. The year-end balance sheet data was derived from audited financial statements but does not include all disclosures
required by GAAP. The results of operations for the interim period are not necessarily indicative of the results expected for the
full year. These unaudited condensed consolidated financial statements, footnote disclosures and other information should be read in
conjunction with the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the
year ended December 31, 2022 filed on March 31, 2023.
The
unaudited condensed consolidated financial statements are presented in US Dollars and include the accounts of the Company and its subsidiaries.
All significant inter-company accounts and transactions have been eliminated in consolidation.
Use
of estimates
The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts
reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Significant areas for
which management uses estimates include:
● |
revenue
recognition at point in time and over time; |
● |
sales
returns at point in time and allowances; |
● |
inventory; |
● |
estimated
lives for tangible and intangible assets; and |
● |
income
tax valuation allowances |
These
estimates require the use of judgment as future events and the effect of these events cannot be predicted with certainty. The estimates
will change as new events occur, as more experience is acquired and as more information is obtained. We evaluate and update our assumptions
and estimates on an ongoing basis and we may consult outside experts to assist as considered necessary.
Cash
and cash equivalents
Cash
and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions
and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.
Accounts
receivable
Accounts
receivable are recorded at the invoiced amount and do not bear interest, which are due within contractual payment terms, generally 30
to 90 days from completion of service. Credit is extended based on evaluation of a customer’s financial condition, the customer
credit-worthiness and their payment history. Accounts receivable outstanding longer than the contractual payment terms are considered
past due. Past due balances over 90 days and over a specified amount are reviewed individually for collectability. At the end of fiscal
year, the Company specifically evaluates individual customer’s financial condition, credit history, and the current economic conditions
to monitor the progress of the collection of accounts receivables. The Company will consider the allowance for doubtful accounts for
any estimated losses resulting from the inability of its customers to make required payments. For the receivables that are past due or
not being paid according to payment terms, the appropriate actions are taken to exhaust all means of collection, including seeking legal
resolution in a court of law. Account balances are charged off against the allowance after all means of collection have been exhausted
and the potential for recovery is considered remote. The Company does not have any off-balance-sheet credit exposure related to its customers.
As of March 31, 2023 and December 31, 2022, there was no allowance for doubtful accounts.
Inventories
Inventories
are stated at the lower of cost or market value (net realizable value), cost being determined on a first-in-first-out method. Costs include
material and manufacturing overhead costs. The Company provides inventory allowances based on excess and obsolete inventories determined
principally by customer demand. As of March 31, 2023 and December 31, 2022, the Company did not record an allowance for obsolete inventories,
nor have there been any write-offs.
Plant
and equipment
Plant
and equipment are stated at cost less accumulated depreciation and accumulated impairment losses, if any. Depreciation is calculated
on the straight-line basis over the following expected useful lives from the date on which they become fully operational and after taking
into account their estimated residual values:
SCHEDULE OF ESTIMATED USEFUL LIVES
| |
Expected useful lives | |
Residual value | |
Furniture, fixture and equipment | |
3 years | |
| 5 | % |
Motor vehicle | |
3.33 to 4 years | |
| 5 | % |
Leasehold improvement | |
2 years | |
| 5 | % |
Expenditures
for repairs and maintenance are expensed as incurred. When assets have been retired or sold, the cost and related accumulated depreciation
are removed from the accounts and any resulting gain or loss is recognized in the results of operations.
Depreciation
expense for the three months ended March 31, 2023 and 2022 were $14,351 and $19,618, respectively.
Intangible
assets
Intangible
assets represented trademarks of their products and are stated at cost less accumulated amortization and any recognized impairment loss.
Amortization is provided over the term of their registrations on a straight-line basis, which is 10 years and will expire in 2028.
Amortization
expense for the three months ended March 31, 2023 and 2022 were $123 and $132, respectively.
Impairment
of long-lived assets
In
accordance with the provisions of Accounting Standards Codification (“ASC”) Topic 360, “Impairment or Disposal of
Long-Lived Assets”, all long-lived assets such as plant and equipment, as well as intangible assets held and used by the Company
are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
Recoverability of assets to be held and used is evaluated by a comparison of the carrying amount of an asset to its estimated future
undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized
is measured by the amount by which the carrying amounts of the assets exceed the fair value of the assets. There has been no impairment
charge for the periods presented.
Revenue
recognition
The
Company adopted ASC 606 – “Revenue from Contracts with Customers” (“ASC Topic 606”). Under ASC
Topic 606, a performance obligation is a promise within a contract to transfer a distinct good or service, or a series of distinct
goods and services, to a customer. Revenue is recognized when performance obligations are satisfied and the customer obtains control
of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be
entitled to receive in exchange for goods or services. Under the standard, a contract’s transaction price is allocated to each
distinct performance obligation. To determine revenue recognition for arrangements that the Company determines are within the scope
of ASC Toipc 606, the Company performs the following five steps:
| ● | identify
the contract with a customer; |
| ● | identify
the performance obligations in the contract; |
| ● | determine
the transaction price; |
| ● | allocate
the transaction price to performance obligations in the contract; and |
| ● | recognize
revenue as the performance obligation is satisfied. |
Currently,
the Company operates two business segments.
Healthcare
Business mainly provides health consulting advisory services and healthcare and wellness products to the customers.
Revenue
is earned from the rendering of health consulting advisory services to the customers. The Company recognizes services revenue over the
period in which such services are performed. Amounts expected to be recognized as revenue within the 12 months following the balance
sheet date are classified as current portion of deferred revenue in the accompanying consolidated balance sheets. Amounts not expected
to be recognized as revenue within the 12 months following the balance sheet date are classified as deferred revenue, net of current
portion.
The
sale and distribution of the healthcare products, such as (i) Nutrition Catering (ii) Special Health Food (iii) Health Supplement and
(iv) Skincare, is the only performance obligation under the fixed-fee arrangements. Revenue is recognized from the sale of their healthcare
products upon delivery to the customers, whereas the title and risk of loss are fully transferred to the customers. The Company records
its revenues, net of value added taxes (“VAT”) on the majority of the products at the rate of 17% on the invoiced value of
sales. The cost, such as shipping cost and material cost, is recognized when the product delivered to the customers. The Company records
its cost including taxes.
Wine
Business mainly provides wine products to the customers, with a right to return. The Company acts as the principal in substantially
all of its customer arrangements and as such, generally records revenues on a gross basis. Revenues exclude any taxes that the Company
collects from customers and remits to tax authorities. Revenue is recognized from the sale of wine products upon delivery to the customers,
whereas the title and risk of loss are fully transferred to the customers. The Company records its revenues, net of value added taxes
(“VAT”) on the majority of the products at the rate of 17%
on the invoiced value of sales. The revenues are presented net of sales returns and discounts. The Company recorded product sales returns
of $0 and
$4,741 for
the three months ended March 31, 2023 and 2022, respectively. The cost, such as shipping cost and material cost, is recognized when the product
delivered to the customers. The Company records its cost including taxes.
Disaggregation
of Revenue
The
following table provides information about disaggregated revenue from customers into the nature of the products and services, and geographic
regions, and includes a reconciliation of the disaggregated revenue with reportable segments.
SCHEDULE
OF DISAGGREGATED REVENUE WITH REPORTABLE SEGMENTS
| |
For the Three Months Ended March 31, 2023 | | |
For the Three Months Ended March 31, 2022 | |
| |
| | |
| |
Consultancy service fee income | |
$ | - | | |
$ | 64,058 | |
Sale of wine products | |
| 12,100 | | |
| 4,741 | |
Sales of healthcare products | |
| 105 | | |
| - | |
| |
| | | |
| | |
TOTAL | |
$ | 12,205 | | |
$ | 68,799 | |
Income
taxes
The
Company adopted the ASC Topic 740, “Income Taxes” (“ASC Topic 740”) provisions of paragraph
740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be
recorded in the condensed consolidated financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit
from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the
taxing authorities, based on the technical merits of the position. The tax benefits recognized in the condensed consolidated
financial statements from such a position should be measured based on the largest benefit that has a greater
than fifty percent (50%) likelihood of being realized upon ultimate settlement.
Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting
in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized
income tax benefits according to the provisions of paragraph 740-10-25-13.
The
estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying
balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred
tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.
Uncertain
tax positions
The
Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the ASC
Topic 740 provisions of Section 740-10-25 for the three months ended March 31, 2023 and 2022.
Foreign
currencies translation
Transactions
denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing
at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated
into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded
in the unaudited condensed consolidated statement of operations.
The
reporting currency of the Company is United States Dollar (“US$”) and the accompanying unaudited condensed consolidated
financial statements have been expressed in US$. In addition, the Company is operating in Hong Kong SAR and the People’s
Republic of China and maintain its books and record in its local currency, Hong Kong Dollars (“HK$”) and Renminbi
(“RMB”), which is a functional currency as being the primary currency of the economic environment in which their
operations are conducted. In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional
currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”,
using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the year.
The gains and losses resulting from translation of financial statements of foreign subsidiaries are recorded as a separate component
of accumulated other comprehensive income within the statements of changes in shareholders’ equity.
Translation
of amounts from HK$ and RMB into US$ has been made at the following exchange rates for the three months ended March 31, 2023 and 2022:
SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES
| |
2023 | | |
2022 | |
Period-end HK$:US$ exchange rate | |
| 0.12739 | | |
| 0.12711 | |
Period average HK$:US$ exchange rate | |
| 0.12758 | | |
| 0.12811 | |
Period-end RMB:US$ exchange rate | |
| 0.14560 | | |
| 0.15764 | |
Period average RMB:US$ exchange rate | |
| 0.14615 | | |
| 0.15752 | |
Net
loss per share
The
Company calculates net loss per share in accordance with ASC Topic 260, “Earnings per Share”. Basic (loss)
income per share is computed by dividing the net (loss) income by the weighted-average number of common shares outstanding during
the period. Diluted (loss) income per share is computed similar to basic (loss) income per share except that the denominator is
increased to include the number of additional common shares that would have been outstanding if the potential common stock
equivalents had been issued and if the additional common shares were dilutive.
Comprehensive
income
ASC
Topic 220, “Comprehensive Income”, establishes standards for reporting and display of comprehensive income, its components
and accumulated balances. Comprehensive income as defined includes all changes in equity during a period from non-owner sources. Accumulated
other comprehensive income, as presented in the accompanying condensed consolidated statements of changes in stockholders’ equity,
consists of changes in unrealized gains and losses on foreign currency translation. This comprehensive income is not included in the
computation of income tax expense or benefit.
Leases
The
Company adopted ASC Topic 842, “Leases” (“ASC Topic 842”), using the modified retrospective approach
through a cumulative-effect adjustment and utilizing the effective date of January 1, 2019 as its date of initial application, with
prior periods unchanged and presented in accordance with the previous guidance in ASC Topic 840, “Leases”
(“ASC Topic 840”).
At
the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and
circumstances present. Leases with a term greater than one year are recognized on the balance sheet as right-of-use (“ROU”)
assets, lease liabilities and long-term lease liabilities. The Company has elected not to recognize on the balance sheet leases with
terms of one year or less. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present
value of lease payments over the expected remaining lease term. However, certain adjustments to the right-of-use asset may be required
for items such as prepaid or accrued lease payments. The interest rate implicit in lease contracts is typically not readily determinable.
As a result, the Company utilizes its incremental borrowing rates, which are the rates incurred to borrow on a collateralized basis over
a similar term an amount equal to the lease payments in a similar economic environment.
In
accordance with the guidance in ASC Topic 842, components of a lease should be split into three categories: lease components (e.g.
land, building, etc.), non-lease components (e.g. common area maintenance, consumables, etc.), and non-components (e.g. property
taxes, insurance, etc.). Subsequently, the fixed and in-substance fixed contract consideration (including any related to
non-components) must be allocated based on the respective relative fair values to the lease components and non-lease
components.
Lease
expense is recognized on a straight-line basis over the lease terms. Lease expense includes amortization of the ROU assets and accretion
of the lease liabilities. Amortization of ROU assets is calculated as the periodic lease cost less accretion of the lease liability.
The amortized period for ROU assets is limited to the expected lease term.
The
Company has elected a practical expedient to combine the lease and non-lease components into a single lease component. The Company also
elected the short-term lease measurement and recognition exemption and does not establish ROU assets or lease liabilities for operating
leases with terms of 12 months or less.
Related
parties
The
Company follows the ASC Topic 850-10, “Related Party” for the identification of related parties and disclosure of related party
transactions.
Pursuant
to section 850-10-20 the related parties include a) affiliates of the Company; b) entities for which investments in their equity securities
would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15,
to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing
trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company;
f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies
of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and
g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership
interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting
parties might be prevented from fully pursuing its own separate interests.
The
financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense
allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the
preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the
nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts
were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding
of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which
income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding
period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the
terms and manner of settlement.
Commitments and contingencies
The
Company follows the ASC Topic 450-20, “Commitments” to report accounting for contingencies. Certain conditions may exist as of
the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or
more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves
an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or
un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or
un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.
If
the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability
can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates
that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then
the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.
Loss
contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.
Management does not believe, based upon information available at this time that these matters will have a material adverse effect on
the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not
materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.
Fair
value Measurement
The
Company follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC Topic
820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC Topic 820-10 establishes a three-tier
fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:
| Level 1 |
Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. |
| Level 2 |
Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. |
| Level 3 |
Pricing inputs that are generally observable inputs and not corroborated by market data. |
Financial
assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar
techniques and at least one significant model assumption or input is unobservable.
The
fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and
the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than
one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of
the instrument.
The
carrying amounts of the Company’s financial assets and liabilities, such as cash and cash equivalents, approximate their fair values
because of the short maturity of these instruments.
Segment Reporting
ASC Topic 280, “Segment
Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s
internal organization structure as well as information about geographical areas, business segments and major customers in consolidated
financial statements. Currently, the Company operates in one reportable operating segment in Hong Kong and China.
Recent
accounting pronouncements
From
time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies and adopted by the Company as of
the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are
not yet effective will not have a material impact on its financial position or results of operations upon adoption.
Accounting
Standards Recently Adopted
Credit Losses– Measurement of Credit Losses on Financial Instruments
In
March 2022, the FASB issued Accounting Standards Update (“ASU”) 2022-02, “Credit Losses – Measurement of Credit
Losses on Financial Instruments (ASC Topic 326): Troubled Debt Restructurings (TDRs) and Vintage Disclosures,” which
eliminates the accounting guidance for TDRs, now requiring an entity to determine whether a modification results in a new loan or a
continuation of an existing loan, as well as expanding disclosures related to modifications and requires disclosure of current
period gross write-offs of financing receivables within the vintage disclosures table. The Company adopted this guidance effective
January 1, 2023, and the adoption of this standard did not have a material impact on its unaudited condensed consolidated financial
statements.
The
Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of
any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.
NOTE 3 – LIQUIDITY AND GOING CONCERN
The accompanying unaudited condensed consolidated
financial statements have been prepared using going concern basis of accounting, which contemplates the realization of assets and the
satisfaction of liabilities in the normal course of business.
For the three months ended March 31, 2023, the Company
incurred a net loss of $107,871 and suffered from a working capital deficit of $141,802 as of March 31, 2023. The continuation of the
Company as a going concern is dependent upon the continued financial support from its stockholders. Management believes the existing stockholders
will provide the additional cash to meet with the Company’s obligations as they become due. However, there is no assurance that
the Company will be successful in securing sufficient funds to sustain the operations.
NOTE
4 - SEGMENT REPORTING
Currently,
the Company has two reportable business segments:
(i) | Healthcare
Segment, mainly provides health consulting advisory services and healthcare and wellness
products to the customers; and |
(ii) |
Wine Segment, mainly provides the wine products to the customers. |
In
the following table, revenue is disaggregated by primary major product line, including a reconciliation of the disaggregated revenue
with the reportable segments.
SUMMARY OF REPORTABLE SEGMENTS
| |
| | | |
| | | |
| | |
| |
Three Months Ended March 31, 2023 | |
| |
Healthcare Segment | | |
Wine Segment | | |
Total | |
Revenue from external customers: | |
| | | |
| | | |
| | |
Sale of healthcare products | |
| 105 | | |
| - | | |
| 105 | |
Sale of wine products | |
| – | | |
| 12,100 | | |
| 12,100 | |
Total revenue | |
| 105 | | |
| 12,100 | | |
| 12,205 | |
| |
| | | |
| | | |
| | |
Cost of sales: | |
| | | |
| | | |
| | |
Sale of healthcare products | |
| (55 | ) | |
| - | | |
| (55 | ) |
Sale of wine products | |
| - | | |
| (9,442 | ) | |
| (9,442 | ) |
Total cost of revenue | |
| (55 | ) | |
| (9,442 | ) | |
| (9,497 | ) |
| |
| | | |
| | | |
| | |
Gross profit | |
| 50 | | |
| 2,658 | | |
| 2,708 | |
| |
| | | |
| | | |
| | |
Operating Expenses | |
| | | |
| | | |
| | |
Selling and distribution | |
| - | | |
| (2,328 | ) | |
| (2,328 | ) |
General and administrative | |
| (62,659 | ) | |
| (45,933 | ) | |
| (108,592 | ) |
Total operating expenses | |
| (62,659 | ) | |
| (48,261 | ) | |
| (110,920 | ) |
| |
| | | |
| | | |
| | |
Segment loss | |
$ | (62,609 | ) | |
$ | (45,603 | ) | |
$ | (108,212 | ) |
| |
| | | |
| | | |
| | |
| |
Three Months Ended March 31, 2022 | |
| |
Healthcare Segment | | |
Wine Segment | | |
Total | |
Revenue from external customers: | |
| | | |
| | | |
| | |
Consulting service income | |
$ | 64,058 | | |
$ | – | | |
$ | 64,058 | |
Sale of wine products | |
| – | | |
| 4,741 | | |
| 4,741 | |
Total revenue | |
| 64,058 | | |
| 4,741 | | |
| 68,799 | |
| |
| | | |
| | | |
| | |
Cost of sales: | |
| | | |
| | | |
| | |
Consulting service income | |
| (14,243 | ) | |
| - | | |
| (14,243 | ) |
Sale of wine products | |
| - | | |
| (4,594 | ) | |
| (4,594 | ) |
Total cost of revenue | |
| (14,243 | ) | |
| (4,594 | ) | |
| (18,837 | ) |
| |
| | | |
| | | |
| | |
Gross profit | |
| 49,815 | | |
| 148 | | |
| 49,962 | |
| |
| | | |
| | | |
| | |
Operating Expenses | |
| | | |
| | | |
| | |
Selling and distribution | |
| - | | |
| (8 | ) | |
| (8 | ) |
General and administrative | |
| (31,479 | ) | |
| (93,450 | ) | |
| (124,929 | ) |
Total operating expenses | |
| (31,479 | ) | |
| (93,458 | ) | |
| (124,937 | ) |
| |
| | | |
| | | |
| | |
Segment (loss) income | |
$ | 18,336 | | |
$ | (93,310 | ) | |
$ | (74,975 | ) |
The
below revenues are based on the countries in which the customer is located. Summarized financial information concerning the geographic
segments is shown in the following tables:
SUMMARY OF GEOGRAPHIC SEGMENTS
| |
For the Three Months Ended March 31, 2023 | | |
For the Three Months Ended March 31, 2022 | |
| |
| | |
| |
Hong Kong | |
$ | - | | |
$ | 64,058 | |
China | |
| 12,205 | | |
| 4,741 | |
| |
| | | |
| | |
TOTAL | |
$ | 12,205 | | |
$ | 68,799 | |
NOTE
5 - DEPOSITS AND OTHER RECEIVABLES
Deposits and other receivables consisted of the following:
SCHEDULE
OF DEPOSITS AND OTHER RECEIVABLE
| |
March 31, 2023 | | |
December 31, 2022 | |
| |
| | |
(Audited) | |
Rental deposits | |
$ | 40,241 | | |
$ | 40,115 | |
Purchase deposits | |
| 19,029 | | |
| 23,835 | |
Other receivables | |
| 2,905 | | |
| 10,863 | |
Deposits
and other receivable | |
$ | 62,175 | | |
$ | 74,813 | |
Purchase
deposits represented deposit payments made to suppliers for daily operation, procurement, which are interest-free, unsecured and received
by the Company when corporation with suppliers are terminated.
NOTE
6 – INVENTORIES
Inventories
consisted of the following:
SCHEDULE OF INVENTORIES
| |
March 31, 2023 | | |
December 31, 2022 | |
| |
| | |
(Audited) | |
Finished goods – Healthcare products | |
| 928 | | |
| - | |
Finished goods – Wine products | |
| 128,705 | | |
| 138,582 | |
Finished goods | |
| 128,705 | | |
| 138,582 | |
Inventories | |
$ | 129,633 | | |
$ | 138,582 | |
For
the three months ended March 31, 2023 and 2022, no allowance for obsolete inventories was recorded by the Company.
NOTE
7 – LEASE
The
Company leased office and warehouse facilities under various non-cancelable operating leases expiring at the term of 1 to 2 year, through
May 16, 2023.
Right
of use assets and lease liability – right of use are as follows:
SCHEDULE OF RIGHT OF USE ASSETS AND LIABILITY
| |
March 31, 2023 | | |
December 31, 2022 | |
| |
| | |
(Audited) | |
Right-of-use assets | |
$ | 6,848 | | |
$ | 20,341 | |
The
lease liability – right of use is as follows:
| |
March 31, 2023 | | |
December 31, 2022 | |
| |
| | |
(Audited) | |
Lease liabilities | |
$ | 7,115 | | |
$ | 21,024 | |
As
of March 31, 2023, the operating lease payment of $13,909 will become matured in the next 12 months.
NOTE
8 – PLANT AND EQUIPMENT
SCHEDULE
OF PROPERTY, PLANT AND EQUIPMENT
| |
March 31, 2023 | | |
December 31, 2022 | |
| |
| | |
(Audited) | |
Motor vehicle | |
$ | 284,255 | | |
$ | 284,255 | |
Furniture, fixture and equipment | |
| 15,465 | | |
| 15,465 | |
Leasehold improvement | |
| 27,358 | | |
| 27,358 | |
Foreign translation adjustment | |
| (3,330 | ) | |
| (4,095 | ) |
Plant and equipment,
gross | |
| 323,748 | | |
| 322,983 | |
| |
| | | |
| | |
Less: accumulated depreciation | |
| (273,016 | ) | |
| (258,665 | ) |
Foreign translation adjustment | |
| (9,487 | ) | |
| (8,823 | ) |
Plant and equipment, net | |
$ | 41,245 | | |
$ | 55,495 | |
Depreciation
expense for the three months ended March 31, 2023 and 2022 were $14,351 and $19,618, respectively.
NOTE
9 – AMOUNTS DUE TO A DIRECTOR AND A RELATED COMPANY
As
of March 31, 2023 and December 31, 2022, the amounts represented temporary advances to the Company by its director and its related company
which were unsecured, interest-free and have no fixed terms of repayments.
NOTE
10 – STOCKHOLDERS’ (DEFICIT) EQUITY
Common
Stock
The
Company is authorized, subject to limitations prescribed by Delaware law, to issue up to 100,000,000 shares of common stock with a nominal
par value of $0.0001.
Dividend
Rights
Subject
to preferences that may apply to shares of preferred stock outstanding at the time, the holders of outstanding shares of our common stock
are entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends
and only then at the times and in the amounts that our board of directors may determine.
Voting
Rights
Each
holder of common stock is entitled to one vote for each share of common stock held on all matters submitted to a vote of stockholders.
Under our Certificate of Incorporation, stockholders do not have the right to cumulate votes for the election of directors.
No
Preemptive or Similar Rights
Our
common stock is not entitled to preemptive rights and is not subject to conversion, redemption or sinking fund provisions.
Right
to Receive Liquidation Distributions
Upon
our dissolution, liquidation or winding-up, the assets legally available for distribution to our stockholders are distributable ratably
among the holders of our common stock, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights
and payment of liquidation preferences, if any, on any outstanding shares of preferred stock.
As
of March 31, 2023, and December 31, 2022, a total of 20,252,309 and 20,252,309 outstanding shares of common stock were issued, respectively.
Preferred
Stock
The
Company is not currently authorized to issue shares of preferred stock. The Certificate of Incorporation however, allows the board of
directors to authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power
or other rights of the holders of the common stock in the event that shares of preferred stock are authorized in the future. The issuance
of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other
things, have the effect of delaying, deferring or preventing a change in control of our company and may adversely affect the market price
of our common stock and the voting and other rights of the holders of common stock. The Company has no current plans to issue any shares
of preferred stock.
NOTE
11 - INCOME TAXES
The
provision for income taxes consisted of the following:
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE
| |
2023 | | |
2022 | |
| |
Three months ended March 31, | |
| |
2023 | | |
2022 | |
| |
| | |
| |
Current tax | |
$ | - | | |
$ | 2,268 | |
Deferred tax | |
| - | | |
| - | |
Income tax expense | |
$ | - | | |
$ | 2,268 | |
The
Company mainly operates in the PRC that is subject to taxes in the governing jurisdictions in which it operates. The effective tax rate
in the years presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax
rate, as follows:
BVI
Under
the current BVI law, the Company is not subject to tax on income.
The
PRC
The
Company’s subsidiary operating in the PRC is subject to the Corporate Income Tax Law of the People’s Republic of China at
a unified income tax rate of 25%. The reconciliation of income tax rate to the effective income tax rate for the three months ended March
31, 2023 and 2022 is as follows:
SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE
| |
2023 | | |
2022 | |
| |
Three months ended March 31, | |
| |
2023 | | |
2022 | |
| |
| | |
| |
Statutory income tax rate | |
| 25 | % | |
| 25 | % |
Income tax expense at statutory rate | |
| (14,199 | ) | |
| (23,245 | ) |
Tax adjustments | |
| 2,304 | | |
| 311 | |
Net operating loss | |
| 14,199 | | |
| 23,245 | |
Income tax expense | |
$ | - | | |
$ | - | |
Hong
Kong
The
Company’s subsidiary operating in Hong Kong is subject to the Hong Kong Profits Tax at the two-tiered profits tax rates from 8.25%
to 16.5% on the estimated assessable profits arising in Hong Kong during the current year, after deducting a tax concession for the tax
year. The reconciliation of income tax rate to the effective income tax rate for the three months ended March 31, 2023 and 2022 is as
follows:
SCHEDULE OF RECONCILIATION TAX RATE TO EFFECTIVE INCOME TAX RATE
| |
2022 | | |
2021 | |
| |
Three months ended March 31, | |
| |
2022 | | |
2021 | |
| |
| | |
| |
Statutory income tax rate | |
| 8.25 | % | |
| 8.25 | % |
Income tax expense at statutory rate | |
| (4,076 | ) | |
| 1,957 | |
Tax adjustments | |
| 2,304 | | |
| 311 | |
Net operating loss | |
| 1,772 | | |
| - | |
Income tax expense | |
$ | - | | |
$ | 2,268 | |
The
following table sets forth the significant components of the deferred tax assets of the Company as of March 31, 2023 and December 31,
2022:
SCHEDULE OF DEFERRED TAX ASSETS
| |
March 31, 2023 | | |
December 31, 2022 | |
| |
| | |
(Audited) | |
Deferred tax assets: | |
| | | |
| | |
Net operating loss carryforwards | |
| | | |
| | |
- United States | |
$ | 151,546 | | |
| 149,874 | |
- Hong Kong | |
| 1,772 | | |
| - | |
- PRC | |
| 323,830 | | |
| 309,631 | |
Net operating loss carryforwards | |
| 477,148 | | |
| 459,505 | |
Less: valuation allowance | |
| (477,148 | ) | |
| (459,505 | ) |
Deferred tax assets, net | |
$ | - | | |
$ | - | |
NOTE
12 - RELATED PARTY TRANSACTIONS
From
time to time, the Company’s director advanced funds to the Company for working capital purpose. Those advances are unsecured, non-interest
bearing and due on demand.
The
Company has been provided free office space by its stockholder. The management determined that such cost is nominal and did not recognize
the rent expense in its condensed consolidated financial statements.
Apart
from the transactions and balances detailed elsewhere in these accompanying unaudited condensed consolidated financial statements, the
Company has no other significant or material related party transactions during the periods presented.
NOTE
13 - CONCENTRATIONS OF RISK
The
Company is exposed to the following concentrations of risk:
For the three months ended March 31, 2023, a single customer represented more than 10% of the Company’s revenues. This customer
accounted for 85% of the Company’s revenues amounting to $10,347.
For the three months ended March 31, 2022, a single customer represented more than 10% of the Company’s revenues. This customer
accounted for 99% of the Company’s revenues amounting to $64,058.
The
Company’s major customers are located in the People’s Republic of China.
For
the three months ended March 31, 2023, No vendor represented more than 10% of the Company’s purchases.
For
the three months ended March 31, 2022, a single vendor represented more than 10% of the Company’s purchases. This vendor accounted
for 100% of the Company’s purchases amounting to $4,594 with $0 of accounts payable.
All
of the Company’s vendors are located in the People’s Republic of China.
(c)
Credit risk
Financial
instruments that are potentially subject to credit risk consist principally of trade receivables. The Company believes the concentration
of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection
terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful
accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.
(d)
Economic and political risk
The
Company’s major operations are conducted in the People’s Republic of China. Accordingly, the political, economic, and legal
environments in PRC, as well as the general state of PRC’s economy may influence the Company’s business, financial condition,
and results of operations.
(e)
Exchange rate risk
The
Company cannot guarantee that the current exchange rate will remain steady; therefore there is a possibility that the Company could post
the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit
depending on exchange rate of RMB converted to US$ on that date. The exchange rate could fluctuate depending on changes in political
and economic environments without notice.
NOTE
14 COMMITMENTS AND CONTINGENCIES
As
of March 31, 2023, the Company has no material commitments or contingencies.
NOTE
15 SUBSEQUENT EVENTS
In
accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and
disclosure of events that occur after the balance sheet date but before unaudited condensed consolidated financial statements are
issued, the Company has evaluated all events or transactions that occurred after March 31, 2023 up through the date the Company
issued the unaudited condensed consolidated financial statements. During the period, the Company did not have any material
recognizable subsequent events.